Clinical Trial: Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Glioblastoma
Study Type: OBSERVATIONAL
Official Title: Evaluating the Role of Cerebrospinal Fluid (CSF) Cell-free DNA (cfDNA) as a Prognostic Biomarker in Glioblastoma
Brief Summary:
The goal of this study is to determine the utility of cerebrospinal fluid (CSF) cell-free DNA (cfDNA) as a prognostic biomarker in glioblastoma (GBM).
Read more